DBVT
Price
$11.60
Change
+$1.30 (+12.62%)
Updated
Jul 3 closing price
Capitalization
295.51M
NCNA
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 7, 11:17 AM (EDT)
Capitalization
20.45M
Interact to see
Advertisement

DBVT vs NCNA

Header iconDBVT vs NCNA Comparison
Open Charts DBVT vs NCNABanner chart's image
DBV Technologies S.A
Price$11.60
Change+$1.30 (+12.62%)
Volume$29.06K
Capitalization295.51M
NuCana
Price$0.05
Change-$0.00 (-0.00%)
Volume$100.53K
Capitalization20.45M
DBVT vs NCNA Comparison Chart in %
Loading...
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DBVT vs. NCNA commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBVT is a Hold and NCNA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (DBVT: $11.60 vs. NCNA: $0.05)
Brand notoriety: DBVT and NCNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DBVT: 49% vs. NCNA: 34%
Market capitalization -- DBVT: $295.51M vs. NCNA: $20.45M
DBVT [@Biotechnology] is valued at $295.51M. NCNA’s [@Biotechnology] market capitalization is $20.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBVT’s FA Score shows that 0 FA rating(s) are green whileNCNA’s FA Score has 0 green FA rating(s).

  • DBVT’s FA Score: 0 green, 5 red.
  • NCNA’s FA Score: 0 green, 5 red.
According to our system of comparison, both DBVT and NCNA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBVT’s TA Score shows that 6 TA indicator(s) are bullish while NCNA’s TA Score has 3 bullish TA indicator(s).

  • DBVT’s TA Score: 6 bullish, 3 bearish.
  • NCNA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, DBVT is a better buy in the short-term than NCNA.

Price Growth

DBVT (@Biotechnology) experienced а +25.95% price change this week, while NCNA (@Biotechnology) price change was -35.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.53%. For the same industry, the average monthly price growth was +13.90%, and the average quarterly price growth was -0.50%.

Industries' Descriptions

@Biotechnology (+5.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DBVT($296M) has a higher market cap than NCNA($20.5M). DBVT YTD gains are higher at: 275.405 vs. NCNA (-95.496). NCNA has higher annual earnings (EBITDA): -16.98M vs. DBVT (-107.89M). DBVT has more cash in the bank: 13M vs. NCNA (3.95M). NCNA has less debt than DBVT: NCNA (173K) vs DBVT (7.51M). DBVT (0) and NCNA (0) have equivalent revenues.
DBVTNCNADBVT / NCNA
Capitalization296M20.5M1,444%
EBITDA-107.89M-16.98M635%
Gain YTD275.405-95.496-288%
P/E RatioN/AN/A-
Revenue00-
Total Cash13M3.95M329%
Total Debt7.51M173K4,339%
FUNDAMENTALS RATINGS
DBVT vs NCNA: Fundamental Ratings
DBVT
NCNA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3497
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NCNA's Valuation (39) in the Biotechnology industry is somewhat better than the same rating for DBVT (93). This means that NCNA’s stock grew somewhat faster than DBVT’s over the last 12 months.

NCNA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DBVT (100). This means that NCNA’s stock grew similarly to DBVT’s over the last 12 months.

NCNA's SMR Rating (99) in the Biotechnology industry is in the same range as DBVT (99). This means that NCNA’s stock grew similarly to DBVT’s over the last 12 months.

DBVT's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for NCNA (97). This means that DBVT’s stock grew somewhat faster than NCNA’s over the last 12 months.

DBVT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NCNA (100). This means that DBVT’s stock grew similarly to NCNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DBVTNCNA
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
76%
Momentum
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
85%
MACD
ODDS (%)
Bullish Trend 5 days ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
78%
Bearish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
81%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 27 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 5 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
DBVT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTKB3.760.15
+4.16%
Cytek Biosciences
RCL334.488.38
+2.57%
Royal Caribbean Group
DRUG28.370.36
+1.29%
Bright Minds Biosciences
VAC80.120.94
+1.19%
MARRIOTT VACATIONS WORLDWIDE Corp
IPW0.64-0.05
-6.82%
iPower

DBVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, DBVT has been closely correlated with WINT. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if DBVT jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBVT
1D Price
Change %
DBVT100%
+12.62%
WINT - DBVT
78%
Closely correlated
+20.68%
NCNA - DBVT
77%
Closely correlated
-5.13%
CDTX - DBVT
77%
Closely correlated
+1.90%
TAOX - DBVT
75%
Closely correlated
+5.20%
RNAC - DBVT
74%
Closely correlated
-1.41%
More

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
-5.13%
CDTX - NCNA
93%
Closely correlated
+1.90%
NBY - NCNA
92%
Closely correlated
+0.62%
WINT - NCNA
92%
Closely correlated
+20.68%
RNAC - NCNA
92%
Closely correlated
-1.41%
TAOX - NCNA
92%
Closely correlated
+5.20%
More